Deep learning enables therapeutic antibody optimization in mammalian cells by deciphering high-dimensional protein sequence space
Mason, D. M.; Friedensohn, S.; Weber, C. R.; Jordi, C.; Wagner, B.; Meng, S.; Gainza, P.; Correia, B.; Reddy, S. T.
Show abstract
Therapeutic antibody optimization is time and resource intensive, largely because it requires low-throughput screening (103 variants) of full-length IgG in mammalian cells, typically resulting in only a few optimized leads. Here, we use deep learning to interrogate and predict antigen-specificity from a massively diverse sequence space to identify globally optimized antibody variants. Using a mammalian display platform and the therapeutic antibody trastuzumab, rationally designed site-directed mutagenesis libraries are introduced by CRISPR/Cas9-mediated homology-directed repair (HDR). Screening and deep sequencing of relatively small libraries (104) produced high quality data capable of training deep neural networks that accurately predict antigen-binding based on antibody sequence. Deep learning is then used to predict millions of antigen binders from an in silico library of ~108 variants, where experimental testing of 30 randomly selected variants showed all 30 retained antigen specificity. The full set of in silico predicted binders is then subjected to multiple developability filters, resulting in thousands of highly-optimized lead candidates. With its scalability and capacity to interrogate high-dimensional protein sequence space, deep learning offers great potential for antibody engineering and optimization.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep learning predictions of TCR-epitope interactions reveal epitope-specific chains in dual alpha T cells 96%
- Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes 96%
- NeoPrecis: Enhancing Immunotherapy Response Prediction through Integration of Qualified Immunogenicity and Clonality-Aware Neoantigen Landscapes 95%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies 97%
- Phage display enables machine learning discovery of cancer antigen specific TCRs 96%
- AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications 95%
Similar papers in this journal
- Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability 94%
- Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling 94%
- A high throughput bispecific antibody discovery pipeline 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.